Jasmine Hudnall, Charles W Schauberger, Garrett Donaldson, Alexander M Barnett, Barbara Miller, Mary C Oldenburg, Thomas D Harter
{"title":"Advance Care Planning for Patients With Substance Use Disorder.","authors":"Jasmine Hudnall, Charles W Schauberger, Garrett Donaldson, Alexander M Barnett, Barbara Miller, Mary C Oldenburg, Thomas D Harter","doi":"10.1097/ADM.0000000000001753","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Patients with substance use disorder (SUD) have a higher risk of mortality and changes in medical decision-making capacity than patients in the general population. However, little is known about their use of advance care planning (ACP). Our aim was to determine the rate of, and variables associated with ACP completion in patients with an SUD diagnosis.</p><p><strong>Methods: </strong>The electronic health records (EHRs) of all patients with an SUD diagnosis from August 2011 through December 2019 were retrospectively reviewed to determine their rate of ACP compared with that of patients without an SUD diagnosis. The presence of an advance directive (AD) in the EHR indicated ACP. Retrospectively matched cohorts, SUD and no SUD, were compared using unadjusted and adjusted statistical methods.</p><p><strong>Results: </strong>Two thousand four hundred forty-four individuals with SUD were identified and propensity-matched with 4888 patients. Patients with SUD had a significantly greater unadjusted rate of ADs (9.9% vs 0.7%, P<0.001) than that of patients with no SUD. Patients with SUD had slightly higher baseline Charlson Comorbidity Index (CCI) scores, a higher rate of Medicaid/Medicare payor status, and higher rates of health care encounters per year. Significant difference in the rate of ADs persisted after adjusting for noted baseline differences in patients with and without SUD.</p><p><strong>Conclusions: </strong>Patients with SUD diagnoses were more likely to have an AD in their EHR than those without. Patients with an SUD diagnosis also had slightly higher CCI scores at baseline, more health care system encounters, and a higher death rate during the study period. Our population was relatively younger than the age at which people typically complete ADs. Further study is warranted to support appropriate communication and documentation regarding this population's health care preferences.</p>","PeriodicalId":14744,"journal":{"name":"Journal of Addiction Medicine","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2026-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Addiction Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/ADM.0000000000001753","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Patients with substance use disorder (SUD) have a higher risk of mortality and changes in medical decision-making capacity than patients in the general population. However, little is known about their use of advance care planning (ACP). Our aim was to determine the rate of, and variables associated with ACP completion in patients with an SUD diagnosis.
Methods: The electronic health records (EHRs) of all patients with an SUD diagnosis from August 2011 through December 2019 were retrospectively reviewed to determine their rate of ACP compared with that of patients without an SUD diagnosis. The presence of an advance directive (AD) in the EHR indicated ACP. Retrospectively matched cohorts, SUD and no SUD, were compared using unadjusted and adjusted statistical methods.
Results: Two thousand four hundred forty-four individuals with SUD were identified and propensity-matched with 4888 patients. Patients with SUD had a significantly greater unadjusted rate of ADs (9.9% vs 0.7%, P<0.001) than that of patients with no SUD. Patients with SUD had slightly higher baseline Charlson Comorbidity Index (CCI) scores, a higher rate of Medicaid/Medicare payor status, and higher rates of health care encounters per year. Significant difference in the rate of ADs persisted after adjusting for noted baseline differences in patients with and without SUD.
Conclusions: Patients with SUD diagnoses were more likely to have an AD in their EHR than those without. Patients with an SUD diagnosis also had slightly higher CCI scores at baseline, more health care system encounters, and a higher death rate during the study period. Our population was relatively younger than the age at which people typically complete ADs. Further study is warranted to support appropriate communication and documentation regarding this population's health care preferences.
期刊介绍:
The mission of Journal of Addiction Medicine, the official peer-reviewed journal of the American Society of Addiction Medicine, is to promote excellence in the practice of addiction medicine and in clinical research as well as to support Addiction Medicine as a mainstream medical sub-specialty.
Under the guidance of an esteemed Editorial Board, peer-reviewed articles published in the Journal focus on developments in addiction medicine as well as on treatment innovations and ethical, economic, forensic, and social topics including:
•addiction and substance use in pregnancy
•adolescent addiction and at-risk use
•the drug-exposed neonate
•pharmacology
•all psychoactive substances relevant to addiction, including alcohol, nicotine, caffeine, marijuana, opioids, stimulants and other prescription and illicit substances
•diagnosis
•neuroimaging techniques
•treatment of special populations
•treatment, early intervention and prevention of alcohol and drug use disorders
•methodological issues in addiction research
•pain and addiction, prescription drug use disorder
•co-occurring addiction, medical and psychiatric disorders
•pathological gambling disorder, sexual and other behavioral addictions
•pathophysiology of addiction
•behavioral and pharmacological treatments
•issues in graduate medical education
•recovery
•health services delivery
•ethical, legal and liability issues in addiction medicine practice
•drug testing
•self- and mutual-help.